Zuranolone is an Orally Active GABAA Receptor Modulator for Postpartum Depression Research
The U.S. Food and Drug Administration approved Zuranolone, the first oral medication indicated to treat postpartum depression (PPD) in adults. PPD is a major depressive episode that typically occurs after…